Table 3. Analysis of factors associated with SARS-CoV-2 IgG positivity.
SARS-CoV-2 IgG | p-valuea | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|
Characteristics | negative | positive | OR (95% CI) | p-value | OR (95% CI) | p-valuec | |
Gender: | 0.849 | 0.849 | |||||
male | 264 (14.2%) | 2 (12.5%) | 1 | ||||
female | 1599 (85.8%) | 14 (87.5%) | 1.16 (0.26‒5.11) | ||||
Age, median, IQR; yearsb | 48 (38‒56) | 50.5 (46‒57.5) | 0.141 | 1.03 (0.99‒1.08) | 0.131 | 1.04 (0.99‒1.09) | 0.093 |
Professional category: | 0.114 | ||||||
other without direct patient contact | 639 (34%) | 4 (25%) | 1 | ||||
nurse | 635 (34%) | 4 (25%) | 1.01 (0.25‒4.04) | 0.992 | |||
physician | 364 (20%) | 7 (44%) | 3.07 (0.89‒10.56) | 0.075 | |||
other with direct patient contact | 225 (12%) | 1 (6%) | 0.71 (0.08‒6.39) | 0.760 | |||
Healthcare department: | 0.716 | 0.717 | |||||
non-clinical | 543 (29%) | 4 (25%) | 1 | ||||
clinical | 1320 (71%) | 12 (75%) | 1.23 (0.40‒3.84) | ||||
Previously tested for SARS-CoV-2 RNA | 0.007 | 0.012 | 0.008 | ||||
no | 1454 (78.05%) | 8 (50%) | 1 | ||||
yes | 409 (21.95%) | 8 (50%) | 3.56 (1.33‒9.53) | 3.82 (1.42‒10.29) |
aChi-squared test.
bMann Whitney U test.
cWald test.